Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Tomtom N.v.

Start price
Target price
Perf. (%)
€3.28
19.09.21
€5.00
19.09.22
-0.05%
02.10.21

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Fair valuation
Innate Pharma S.a.

Start price
Target price
Perf. (%)
€6.60
18.09.21
€3.00
18.09.22
-26.06%
02.10.21

Lower EBIT Margin than peer group
Bad rating
Increased challenges to pay loans and raise capital
Below average Management
buy
Fastned B.V.

Start price
Target price
Perf. (%)
€55.40
30.06.21
€58.00
30.06.22
-0.54%
29.09.21

Could be worthwhile Investment >10% per year
buy
Cherry AG

Start price
Target price
Perf. (%)
€37.50
10.08.21
€38.50
10.08.22
-16.80%
28.09.21

Could be worthwhile Investment >10% per year
buy
Adevinta Asa

Start price
Target price
Perf. (%)
€16.82
11.08.21
€17.50
11.08.22
-16.74%
28.09.21

Could be worthwhile Investment >10% per year
buy
Nikola Corp.

Start price
Target price
Perf. (%)
€8.10
23.08.21
-
23.08.25
26.89%
28.09.21

Risky Investment
buy
Appen Ltd.

Start price
Target price
Perf. (%)
€16.20
01.01.21
€23.00
01.01.22
-63.58%
24.09.21

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth > 30% per year expected
Higher EBIT margin than peer group
buy
Global Li-ion Graphite Corp.

Start price
Target price
Perf. (%)
€0.17
11.02.21
€0.60
11.02.22
-72.71%
23.09.21

buy
Fiore Cannabis Ltd.

Start price
Target price
Perf. (%)
€0.17
12.02.21
€1.00
12.02.22
-70.47%
23.09.21

Nikola Corp.

Start price
Target price
Perf. (%)
€34.10
20.07.20
€0.80
04.11.21
-73.00%
19.09.21

Risky Investment
EBIT decline > 20% expected
overvalued
Very low/no dividend yield expected
Muehl Product & Service AG

Start price
Target price
Perf. (%)
€3.89
04.09.21
€1.93
04.09.22
-0.83%
18.09.21

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Lower EBIT Margin than peer group
buy
Medincell S.a.

Start price
Target price
Perf. (%)
€10.14
03.09.21
€12.00
03.09.22
-3.75%
16.09.21

Could be worthwhile Investment >10% per year
Neoen S.a.

Start price
Target price
Perf. (%)
€36.06
24.06.21
€33.00
24.06.22
-7.93%
16.09.21

Could be worthwhile Investment >10% per year
buy
Seche Environnement S.a.

Start price
Target price
Perf. (%)
€19.30
15.09.21
€12.00
-
16.09.21

Could be worthwhile Investment >10% per year
buy
Pharmacyte Biotech Inc.

Start price
Target price
Perf. (%)
€3.05
25.08.21
-
25.08.22
-8.85%
14.09.21

Could be worthwhile Investment >10% per year
buy
Moxian Inc.

Start price
Target price
Perf. (%)
€5.80
10.08.21
-
10.08.22
6.90%
06.09.21

Could be worthwhile Investment >10% per year
Top 10 in its market
buy
Mustgrow Biologics Corp.

Start price
Target price
Perf. (%)
€1.70
28.08.21
-
28.08.22
17.06%
04.09.21

Risky Investment
buy
Pharmacyte Biotech Inc.

Start price
Target price
Perf. (%)
€3.54
23.08.21
€6.00
23.08.22
-22.03%
04.09.21

Could be worthwhile Investment >10% per year
Good culture
Innovative
Few uniques
buy
Navya S.a.

Start price
Target price
Perf. (%)
€2.20
19.08.21
€2.55
19.08.22
23.87%
30.08.21

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Very Future proof/growth oriented business model
buy
Kaixin Auto Holdings

Start price
Target price
Perf. (%)
€2.50
08.08.21
€4.00
08.08.22
17.03%
21.08.21

Could be worthwhile Investment >10% per year
Good culture
Innovative
Dependend from some customers or products
Tuerkiye Halk Bankasi A.s.

Start price
Target price
Perf. (%)
€0.91
07.08.21
€0.000
07.08.22
1.11%
21.08.21

EBIT decline/stagnation expected
High valuation
Low dividend yield expected
negative Cash Flow expected
Everarc Holdings Ltd.

Start price
Target price
Perf. (%)
€8.90
07.08.21
€4.00
07.08.22
-27.53%
21.08.21

Little known brand
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Kaixin Auto Holdings

Start price
Target price
Perf. (%)
€2.50
07.08.21
€1.00
07.08.22
17.03%
21.08.21

Risky balance sheet
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
buy
Navya S.a.

Start price
Target price
Perf. (%)
€1.77
13.08.21
€2.70
13.08.22
24.73%
19.08.21

Could be worthwhile Investment >10% per year
Top 10 in its market
Known brand
Very Future proof/growth oriented business model
buy
Grupo Clarin S.a.

Start price
Target price
Perf. (%)
€1.20
28.06.21
€1.00
28.06.22
-
12.08.21

Future proof or reliable business model
Top 10 in its market
Higher risks for its business